Kimberly-Clark
KMB
96.48
-0.29
-0.30%
Kimberly-Clark
US · KMB
#638 by market cap
Listed 1970
96.48
-0.29
-0.30%
Live - 5344 symbols - heartbeat 102s ago
· 2026-10-08 07:08
Pre-market
96.33
-0.16%
After-hours
97.33
+0.88%
Overnight
96.48
0.00%
- Market cap
- 32.09B
- P/E (TTM)i
- 16.44
- P/Bi
- 18.34
- EPSi
- 6.07
- Div yieldi
- 5.27%
- 52W posi
- 24%
Reader sentiment
Are you bullish or bearish on KMB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 8 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.2 percentage points.
Institutional ownership
- Held by institutions
- 99.26% -0.20pp
- Institutions
- 1,969 -8
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund80.95%
Hedge Fund5.93%
Public Company5.59%
Private Company2.22%
Sovereign Wealth Fund1.76%
Government Pension Fund1.55%
Family Office/Trust0.52%
Insurance Company0.33%
Individual/Insider0.26%
Other0.88%
Top holders as of 2026-06-30
BlackRock
9.72% · 32.32M sh
Vanguard Capital Management, LLC
7.08% · 23.54M sh
State Street Global Advisors
6.34% · 21.08M sh
Vanguard Portfolio Management, LLC
4.84% · 16.10M sh
FMR
3.50% · 11.65M sh
Geode Capital Management, LLC
3.37% · 11.20M sh
Charles Schwab Investment Management
3.25% · 10.81M sh
MFS Investment Management
2.45% · 8.16M sh
UBS Asset Management
2.33% · 7.75M sh
Two Sigma Investments, LP
2.12% · 7.05M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 28 buys · 17 sells
| Name | Role | Stake |
|---|---|---|
| Michael Hsu | Chairperson & CEO | 0.11% |
| Russell Torres | President of North America Consumer Business | 0.03% |
| Jeffrey Melucci | Chief Business Development & Legal Officer | 0.02% |
| Mae Jemison | Independent Director | 0.02% |
| Ehab Abou-Oaf | President of Kimberly-Clark Professional | 0.02% |
| Nelson Urdaneta | Senior Vice President | 0.01% |
| Tamera Fenske | Senior VP & Chief Supply Chain Officer | 0.01% |
| Sandra R. Karrmann | Chief Human Resources Officer | 0.01% |
| Christa Quarles | Independent Director | 0.00% |
| Zackery Hicks | Chief Digital & Technology Officer | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-31 | Suzana Blades | General Counsel | Initial Statement of Beneficial | 0 | -- |
| 2026-07-30 | Craig Slavtcheff | Chief Research & Development Officer | Derivative Exercise and Sale | -2,245 | $109.31 |
| 2026-07-30 | Craig Slavtcheff | Chief Research & Development Officer | Derivative Exercise and Retained | +3,034 | -- |
| 2026-07-30 | Patricia Aparecida Corsi | Global Chief Growth Officer | Derivative Exercise and Sale | -404 | $109.31 |
| 2026-07-30 | Patricia Aparecida Corsi | Global Chief Growth Officer | Derivative Exercise and Retained | +562 | -- |
| 2026-05-05 | Andrew Scribner | Vice President | Open Market Disposition | -4,095 | $98.00 |
| 2026-05-03 | Katy Chen | President of International Personal Care | Derivative Exercise and Sale | -1,596 | $95.34 |
| 2026-04-30 | Russell Torres | President of North America Consumer Business | Derivative Exercise and Sale | -2,876 | $97.67 |
| 2026-04-30 | Russell Torres | President of North America Consumer Business | Other Derivative Acquisition | +17,610 | -- |
| 2026-04-30 | Russell Torres | President of North America Consumer Business | Derivative Exercise and Retained | +4,428 | -- |
| 2026-04-30 | Jeffrey Melucci | Chief Business Development & Legal Officer | Derivative Exercise and Sale | -2,382 | $97.67 |
| 2026-04-30 | Jeffrey Melucci | Chief Business Development & Legal Officer | Other Derivative Acquisition | +13,924 | -- |
| 2026-04-30 | Jeffrey Melucci | Chief Business Development & Legal Officer | Derivative Exercise and Retained | +3,668 | -- |
| 2026-04-30 | Craig Slavtcheff | Chief Research & Development Officer | Derivative Exercise and Sale | -535 | $97.67 |
| 2026-04-30 | Craig Slavtcheff | Chief Research & Development Officer | Other Derivative Acquisition | +5,324 | -- |
| 2026-04-30 | Craig Slavtcheff | Chief Research & Development Officer | Derivative Exercise and Retained | +722 | -- |
| 2026-04-30 | Michael Hsu | Chairperson & CEO | Derivative Exercise and Sale | -8,505 | $97.67 |
| 2026-04-30 | Michael Hsu | Chairperson & CEO | Other Derivative Acquisition | +49,145 | -- |
| 2026-04-30 | Michael Hsu | Chairperson & CEO | Derivative Exercise and Retained | +13,107 | -- |
| 2026-04-30 | Nelson Urdaneta | Senior Vice President | Derivative Exercise and Sale | -2,646 | $97.67 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:08:17 · For reference only, not investment advice and not tailored to your situation.